tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tenax Therapeutics Reports Increased R&D Expenses Amid Clinical Trials
PremiumCompany AnnouncementsTenax Therapeutics Reports Increased R&D Expenses Amid Clinical Trials
1M ago
Tenax Therapeutics reports Q3 EPS (40c), consensus ($1.12)
Premium
The Fly
Tenax Therapeutics reports Q3 EPS (40c), consensus ($1.12)
1M ago
TENX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TENX Earnings this Week: How Will it Perform?
1M ago
Tenax Therapeutics Expands Licensing Agreement with Orion
PremiumCompany AnnouncementsTenax Therapeutics Expands Licensing Agreement with Orion
3M ago
Promising Potential of Tenax Therapeutics’ TNX-103 Drives Buy Rating Amid Positive Phase 2 Results and Anticipated Phase 3 Trial
Premium
Ratings
Promising Potential of Tenax Therapeutics’ TNX-103 Drives Buy Rating Amid Positive Phase 2 Results and Anticipated Phase 3 Trial
3M ago
Tenax Therapeutics initiated with an Overweight at Piper Sandler
Premium
The Fly
Tenax Therapeutics initiated with an Overweight at Piper Sandler
3M ago
Tenax Therapeutics Approves Officer Exculpation Amendment
PremiumCompany AnnouncementsTenax Therapeutics Approves Officer Exculpation Amendment
6M ago
Tenax Therapeutics Reports Increased Losses Amid Strategic Investments
Premium
Company Announcements
Tenax Therapeutics Reports Increased Losses Amid Strategic Investments
7M ago
Positive Buy Rating for Tenax Therapeutics Driven by Promising Clinical Trials and Strong Financial Position
Premium
Ratings
Positive Buy Rating for Tenax Therapeutics Driven by Promising Clinical Trials and Strong Financial Position
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100